𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Misonidazole parameters in the treatment of malignant gliomas

✍ Scribed by D.A. Pistenma; T.A. Strike

Publisher
Elsevier Science
Year
1981
Tongue
English
Weight
97 KB
Volume
7
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Temozolomide in the treatment of recurre
Temozolomide in the treatment of recurrent malignant glioma
✍ Susan M. Chang; Philip Theodosopoulos; Kathleen Lamborn; Mary Malec; Jane Rabbit πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Options for chemotherapy at the time of recurrence in patients with malignant glioma are limited. The authors describe the efficacy and safety results of their institution's open‐label, compassionate‐use protocol of temozolomide for patients with recurrent malignant gliom

Activity of high-dose cyclophosphamide i
Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas
✍ McCowage, Geoffrey B.; Friedman, Henry S.; Moghrabi, Albert; Kerby, Tracy; Ferre πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 3 views

Seventeen patients less than or equal to 20 years of age with newly diagnosed (n = 10) or recurrent (n = 7) malignant gliomas (anaplastic astrocytoma and glioblastoma multiforme) were treated with cyclophosphamide in association with hematopoietic cytokines (GM-CSF or G-CSF). Cyclophosphamide was gi